Dr. Kris B. Siemionow, M.D., Ph.D. is the founder and principal of Siemionow Ventures (siemionow.com), a life-sciences and deep technology focused venture building and crossover fund investing in the most breakthrough ideas that will revolutionize healthcare.
Prior to starting SV, Dr. Siemionow was a board-certified spine surgeon and Tenured Associate Professor of Orthopaedics and Neurosurgery at the University of Illinois in Chicago.
As an entrepreneur Dr. Siemionow focuses on applying machine learning technologies to life-sciences, biotech, and medical devices.
Dr. Siemionow was the founder and CEO of HoloSurgical, a digital surgery company, which performed the first in man surgery with its augmented reality and artificial intelligence system on January 9th, 2019. The Company was acquired in October of 2020.
Dr. Siemionow was the founder of Inteneural Networks Inc, a company developing AI tools for brain MRI analytics. The company was acquired in December of 2021.
Dr. Siemionow is co-founder and director at Dystrogen Therapeutics, a clinical stage cell engineering company, which is developing chimeric cell therapies for musculoskeletal, neurologic, and blood disorders. www.dystrogen.com
Dr Siemionow is co-founder and director at Dystrogen Gene Therapies, which is developing an RNAi based approach for CAG repeat disorders like Huntington’s disease. www.dystrogene.com
Dr. Siemionow has published over 100 scientific articles focusing on digital surgery, artificial intelligence, cell therapy, and neurosurgery. He holds multiple patents for developing devices and technologies used in nerve regeneration, digital surgery, cardiology, spine surgery, cell therapy many of which have been commercialized. His PhD focused on studying the effects of inflammation on the central and peripheral nervous system.
Dr. Siemionow is co-founder of Global Spine Outreach. As part of Global Spine Outreach, Dr. Siemionow performed surgery in several European and Central American cities. Dr. Siemionow also participated in spine surgery missions to Uganda, East Africa, where he treated both children and adults suffering from spinal trauma, scoliosis, tumors, and infection.
Dr. Siemionow completed a residency in Orthopaedic Surgery at the Cleveland Clinic in Cleveland, Ohio and fellowship training in Adult Spine Surgery at Rush University Medical Center and a Pediatric Spine Fellowship at the Shriners Hospital for Children.
Dr. Kris B. Siemionow, M.D., Ph.D. is the founder and principal of Siemionow Ventures (siemionow.com), a life-sciences and deep technology focused venture building and crossover fund investing in the most breakthrough ideas that will revolutionize healthcare.
Prior to starting SV, Dr. Siemionow was a board-certified spine surgeon and Tenured Associate Professor of Orthopaedics and Neurosurgery at the University of Illinois in Chicago.
As an entrepreneur Dr. Siemionow focuses on applying machine learning technologies to life-sciences, biotech, and medical devices.
Dr. Siemionow was the founder and CEO of HoloSurgical, a digital surgery company, which performed the first in man surgery with its augmented reality and artificial intelligence system on January 9th, 2019. The Company was acquired in October of 2020.
Dr. Siemionow was the founder of Inteneural Networks Inc, a company developing AI tools for brain MRI analytics. The company was acquired in December of 2021.
Dr. Siemionow is co-founder and director at Dystrogen Therapeutics, a clinical stage cell engineering company, which is developing chimeric cell therapies for musculoskeletal, neurologic, and blood disorders. www.dystrogen.com
Dr Siemionow is co-founder and director at Dystrogen Gene Therapies, which is developing an RNAi based approach for CAG repeat disorders like Huntington’s disease. www.dystrogene.com
Dr. Siemionow has published over 100 scientific articles focusing on digital surgery, artificial intelligence, cell therapy, and neurosurgery. He holds multiple patents for developing devices and technologies used in nerve regeneration, digital surgery, cardiology, spine surgery, cell therapy many of which have been commercialized. His PhD focused on studying the effects of inflammation on the central and peripheral nervous system.
Dr. Siemionow is co-founder of Global Spine Outreach. As part of Global Spine Outreach, Dr. Siemionow performed surgery in several European and Central American cities. Dr. Siemionow also participated in spine surgery missions to Uganda, East Africa, where he treated both children and adults suffering from spinal trauma, scoliosis, tumors, and infection.
Dr. Siemionow completed a residency in Orthopaedic Surgery at the Cleveland Clinic in Cleveland, Ohio and fellowship training in Adult Spine Surgery at Rush University Medical Center and a Pediatric Spine Fellowship at the Shriners Hospital for Children.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy